Related Experiment Videos
Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing
Aaron S Kesselheim1, Steven Woloshin2, Zhigang Lu1
1Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
JAMA Internal Medicine
|January 23, 2019
Abstract
No abstract available in PubMed .